Artelo Biosciences, Inc. – NASDAQ:ARTL
Artelo Biosciences stock price today
$9.75
+8.69
+819.81%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 7 hours
Artelo Biosciences stock price monthly change
-17.83%
month
Artelo Biosciences stock price quarterly change
-17.83%
quarter
Artelo Biosciences stock price yearly change
-20.91%
year
Artelo Biosciences key metrics
Market Cap | 3.06M |
Enterprise value | 625.79K |
P/E | -0.76 |
EV/Sales | N/A |
EV/EBITDA | -0.04 |
Price/Sales | N/A |
Price/Book | 0.38 |
PEG ratio | N/A |
EPS | -3.24 |
Revenue | N/A |
EBITDA | -7.69M |
Income | -9.29M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeArtelo Biosciences stock price history
Artelo Biosciences stock forecast
Artelo Biosciences financial statements
| Dec 2022 | 0 | -3.19M | |
|---|---|---|---|
| Mar 2023 | 0 | -2.04M | |
| Jun 2023 | 0 | -1.59M | |
| Sep 2023 | 0 | -2.44M |
| Jun 2023 | 0 | -1.59M | |
|---|---|---|---|
| Sep 2023 | 0 | -2.44M | |
| Sep 2025 | 0 | -589.8K | |
| Dec 2025 | 0 | -353.88K |
Analysts Price target
Financials & Ratios estimates
| Dec 2022 | 20424000 | 1.02M | 5% |
|---|---|---|---|
| Mar 2023 | 18478000 | 840K | 4.55% |
| Jun 2023 | 16877000 | 609K | 3.61% |
| Sep 2023 | 15499000 | 921K | 5.94% |
| Sep 2022 | -1.69M | -3.08M | 0 |
|---|---|---|---|
| Dec 2022 | -2.29M | 1.79M | 134K |
| Mar 2023 | -2.18M | 2.19M | 0 |
| Jun 2023 | -1.62M | 399K | -1.25M |
Artelo Biosciences alternative data
| Aug 2023 | 5 |
|---|---|
| Sep 2023 | 5 |
| Oct 2023 | 5 |
| Nov 2023 | 5 |
| Dec 2023 | 5 |
| Jan 2024 | 5 |
| Feb 2024 | 5 |
| Apr 2024 | 5 |
| May 2024 | 6 |
| Jun 2024 | 5 |
| Jul 2024 | 5 |
Artelo Biosciences other data
2.89%
-48.36%
of ARTL is owned by hedge funds
6.59K
-110.45K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Aug 2022 | 2400 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | GORGAS GREGORY D. director: Pres, C.. | Common Stock | 1,200 | $4 | $4,800 | ||
Purchase | GORGAS GREGORY D. director: Pres, C.. | Common Stock | 1,200 | $4.03 | $4,836 | ||
Purchase | GORGAS GREGORY D. director, officer.. | Common Stock | 8,500 | N/A | N/A | ||
Purchase | GORGAS GREGORY D. director, officer.. | Warrant (Right to Buy) | 1,600 | N/A | N/A | ||
Purchase | GORGAS GREGORY D. director, officer.. | Common Stock | 4,200 | N/A | N/A | ||
Purchase | GORGAS GREGORY D. director, officer.. | Common Stock | 4,167 | N/A | N/A | ||
Purchase | MATSUI CONNIE director | Common Stock | 41,667 | $1.2 | $50,000 | ||
Purchase | GORGAS GREGORY D. director, officer.. | Common Stock | 2,400 | $2.21 | $5,304 | ||
Purchase | GORGAS GREGORY D. director, officer.. | Common Stock | 2,500 | N/A | N/A | ||
Purchase | GORGAS GREGORY D. director, officer.. | Common Stock | 2,500 | $2.28 | $5,703 |
| Patent |
|---|
Application Filling date: 31 Mar 2020 Issue date: 30 Sep 2021 |
Application Filling date: 26 Apr 2019 Issue date: 3 Oct 2019 |
-
What's the price of Artelo Biosciences stock today?
One share of Artelo Biosciences stock can currently be purchased for approximately $9.75.
-
When is Artelo Biosciences's next earnings date?
Unfortunately, Artelo Biosciences's (ARTL) next earnings date is currently unknown.
-
Does Artelo Biosciences pay dividends?
No, Artelo Biosciences does not pay dividends.
-
How much money does Artelo Biosciences make?
Artelo Biosciences has a market capitalization of 3.06M.
-
What is Artelo Biosciences's stock symbol?
Artelo Biosciences, Inc. is traded on the NASDAQ under the ticker symbol "ARTL".
-
What is Artelo Biosciences's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Artelo Biosciences?
Shares of Artelo Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Artelo Biosciences's key executives?
Artelo Biosciences's management team includes the following people:
- Mr. Gregory D. Gorgas Pres, Chief Executive Officer, Chief Financial Officer, Treasurer, Sec. & Director(age: 62, pay: $631,540)
-
How many employees does Artelo Biosciences have?
As Jul 2024, Artelo Biosciences employs 5 workers.
-
When Artelo Biosciences went public?
Artelo Biosciences, Inc. is publicly traded company for more then 6 years since IPO on 21 Jun 2019.
-
What is Artelo Biosciences's official website?
The official website for Artelo Biosciences is artelobio.com.
-
Where are Artelo Biosciences's headquarters?
Artelo Biosciences is headquartered at 505 Lomas Santa Fe, Solana Beach, CA.
-
How can i contact Artelo Biosciences?
Artelo Biosciences's mailing address is 505 Lomas Santa Fe, Solana Beach, CA and company can be reached via phone at 858 925 7049.
Artelo Biosciences company profile:
Artelo Biosciences, Inc.
artelobio.comExchange:
NASDAQ
Full time employees:
5
Industry:
Biotechnology
Sector:
Healthcare
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.
505 Lomas Santa Fe
Solana Beach, CA 92075
Solana Beach, CA 92075
CIK: 0001621221
ISIN: US04301G5080
CUSIP: 04301G201
